Khaitan & Co Advised Kotak Life Sciences Fund I And Alkemi Venture Fund II Scheme I On Investment In Zeroharm Sciences
Khaitan & Co advised Kotak Life Sciences Fund I and Alkemi Venture Fund II Scheme I on investment in Zeroharm Sciences
The leading Indian law firm, Khaitan & Co advised Kotak Life Sciences Fund I and Alkemi Venture Fund II Scheme I on their primary investment in Zeroharm Sciences Private Limited, a nutraceutical company focused on innovative health solutions.
The Khaitan & Co core team comprised Sanchit Agarwal (Partner), Pulkit Chaturvedi (Principal Associate), Aditi Gupta (Senior Associate), Jubin Jay (Senior Associate), Daryl Menezes (Associate), Shriya Garg (Associate), and Sameer Parihar (Associate).
Click to know more about Khaitan & Co
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.
